PTC THERAPEUTICS

Lobbying Spend

—

Filings

Firms Hired

Active Period

2016–2026

Lobbying Spend by Year

Client-reported lobbying expenses on LDA filings

Year	Lobbying Spend	Filings	Firms
2026	—	3	1
2025	—	6	2
2024	—	12	2
2023	—	13	2
2022	—	4	1
2021	—	4	1
2020	—	4	1
2019	—	4	3
2018	—	9	2
2017	—	6	2
2016	—	2	1

Lobbying firms retained by this client; amounts are client-reported expenses when available

Firm Name	Reported Spend	Filings
BGR GOVERNMENT AFFAIRS	—	29
TAYLOR STRATEGIES	—	30
CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.	—	8

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
HOUSE OF REPRESENTATIVES	52
SENATE	52
Health & Human Services, Dept of (HHS)	29
Food & Drug Administration (FDA)	20
Centers For Medicare and Medicaid Services (CMS)	11

Most frequently reported lobbying issues

Issue Code	Description	Reports
Health Issues	Health Issues	36
Budget/Appropriations	Budget/Appropriations	21
Medicare/Medicaid	Medicare/Medicaid	5
Medical/Disease Research/Clinical Labs	Medical/Disease Research/Clinical Labs	2

PTC THERAPEUTICS — Lobbying Disclosure | Poliscope